Related Experiment Video
Updated: Aug 7, 2026

Thin Film Composite Silicon Elastomers for Cell Culture and Skin Applications: Manufacturing and Characterization
Published on: July 3, 2018
Effect of zymosan-activated plasma on the deformability of rabbit polymorphonuclear leukocytes
H Inano1, D English, C M Doerschuk
1University of British Columbia Pulmonary Research Laboratory, St. Paul's Hospital, Vancouver, Canada.
Abstract:
Intravascular infusion of inflammatory mediators causes a sudden neutropenia due to the sequestration of polymorphonuclear leukocytes (PMN) within the microvasculature of the lung and other organs. This sequestration could be due to a decrease in the ability of PMN to deform and pass through the narrow capillary bed. The purpose of this study was to determine if the complement fragments present in zymosan-activated plasma (ZAP) caused a rapid stiffening of PMN. The PMN deformability was determined by measuring the pressure required to pass PMN through a polycarbonate filter containing 5-micron pores at a constant flow rate as well as the extraction of PMN compared with red blood cells and 125I-labeled albumin by the filter. The role of the cytoskeleton in PMN deformation was examined in studies where F-actin formation was inhibited using cytochalasin B or microtubule assembly was inhibited using colchicine. The results showed that treatment with ZAP induced a rapid decrease in PMN deformability. Inhibiting the formation of F-actin made the unstimulated PMN more deformable and reduced the stiffening induced by ZAP. In contrast, inhibition of microtubule reassembly did not alter either normal deformability or the ZAP-induced decrease in deformability. In vivo, colchicine increased normal PMN margination but did not inhibit the rapid sequestration of PMN induced by infusion of ZAP. These studies indicate that ZAP induces a rapid decrease in PMN deformability that is mediated through the cytoskeleton. They suggest that this decrease is due to the polymerization of F-actin.
Insights
Zymosan-activated plasma (ZAP) causes rapid stiffening of polymorphonuclear leukocytes (PMN), impairing their ability to deform. This PMN stiffening, mediated by F-actin polymerization, contributes to neutropenia during inflammation.
Area of Science:
- Immunology
- Cell Biology
- Hematology
Background:
- Inflammatory mediators cause neutropenia via polymorphonuclear leukocyte (PMN) sequestration in microvasculature.
- PMN sequestration may result from reduced deformability, hindering passage through capillaries.
Purpose of the Study:
- To investigate if complement fragments in zymosan-activated plasma (ZAP) induce rapid PMN stiffening.
- To elucidate the role of the cytoskeleton in ZAP-induced changes in PMN deformability.
Main Methods:
- PMN deformability assessed by pressure filtration through 5-micron pores.
- F-actin and microtubule assembly inhibition using cytochalasin B and colchicine, respectively.
- In vivo studies evaluating PMN margination and sequestration.
Main Results:
- ZAP treatment rapidly decreased PMN deformability.
- Inhibition of F-actin formation enhanced PMN deformability and reduced ZAP-induced stiffening.
- Microtubule inhibition did not affect normal or ZAP-induced PMN deformability.
Conclusions:
- ZAP induces rapid PMN stiffening mediated by the cytoskeleton.
- F-actin polymerization appears to be the primary mechanism behind ZAP-induced PMN deformability reduction.
- These findings offer insights into inflammatory processes and neutropenia.

